| Brand Name | BI-MENTUM CEMENTED CUP 59 |
| Common Device Name | PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER, CEMENTED OR NON-POROUS |
| Manufacturer (Section D) |
| S.E.R.F SOCIETE DETUDES RECHERCHE FABRICATION |
| 85 avenue des bruyeres |
| 69150 decines-charpieu |
| decines 69150 |
| FR 69150 |
|
| Manufacturer (Section G) |
| S.E.R.F SOCIETE DETUDES RECHERCHE FABRICATION |
| 85 avenue des bruyeres |
| 69150 decines-charpieu |
| decines 69150 |
|
FR
69150
|
|
| Manufacturer Contact |
|
jean-denys
marechal
|
| 85 avenue des bruyeres |
| 69150 decines-charpieu |
| decines 69150
|
|
FR
69150
|
|
472056010
|
|
| MDR Report Key | 23300134 |
| Report Number | 3008668801-2025-00155 |
| Device Sequence Number | 4889804 |
| Product Code |
LZO
|
| UDI-Device Identifier | 03662200015467 |
| UDI-Public | 03662200015467 |
| Combination Product (Y/N) | N |
| Initial Reporter State | SC |
| Initial Reporter Country | US |
| PMA/510(K) Number | K181744 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Device Explanted Year | 2025 |
| Reporter Type |
Manufacturer
|
| Report Source |
Other |
| Initial Reporter Occupation |
Other
|
| Type of Report
| Initial |
| Report Date (Section B) |
10/13/2025 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Health Professional
|
| Device Expiration Date | 05/31/2026 |
| Device Catalogue Number | DS4901159 |
| Device Lot Number | 2012039A |
| Was Device Available for Evaluation? |
No
|
| Type of Report(Section G) | Initial |
| Initial Date Received by Manufacturer | 09/18/2025 |
| Initial Report FDA Received Date | 10/15/2025 |
| Was Device Evaluated by Manufacturer? (Y/N) |
No
|
| Date Device Manufactured | 06/04/2021 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
| Outcome Attributed to Adverse Event |
Hospitalization;
Required Intervention;
|
| Patient Sex | Male |